A detailed history of Met Life Investment Management, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 131,029 shares of ARWR stock, worth $2.57 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
131,029
Previous 132,131 0.83%
Holding current value
$2.57 Million
Previous $3.43 Million 26.15%
% of portfolio
0.01%
Previous 0.02%

Shares

71 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$19.36 - $29.54 $21,334 - $32,553
-1,102 Reduced 0.83%
131,029 $2.54 Million
Q2 2024

Aug 13, 2024

BUY
$21.87 - $28.24 $136,665 - $176,471
6,249 Added 4.96%
132,131 $3.43 Million
Q1 2024

May 14, 2024

BUY
$27.21 - $39.48 $3.43 Million - $4.97 Million
125,882 New
125,882 $3.6 Million
Q4 2023

Feb 14, 2024

SELL
$21.2 - $31.03 $20,097 - $29,416
-948 Reduced 0.83%
112,823 $3.45 Million
Q3 2023

May 09, 2024

SELL
$26.2 - $36.08 $118,555 - $163,262
-4,525 Reduced 3.83%
113,771 $3.06 Million
Q3 2023

Apr 29, 2024

SELL
$26.2 - $36.08 $69,194 - $95,287
-2,641 Reduced 2.27%
113,771 $3.06 Million
Q3 2023

Nov 14, 2023

SELL
$26.2 - $36.08 $69,194 - $95,287
-2,641 Reduced 2.27%
113,771 $3.06 Million
Q2 2023

Apr 29, 2024

BUY
$25.16 - $41.38 $2.93 Million - $4.82 Million
116,412 New
116,412 $4.15 Million
Q2 2023

Aug 10, 2023

SELL
$25.16 - $41.38 $47,401 - $77,959
-1,884 Reduced 1.59%
116,412 $4.15 Million
Q1 2023

May 09, 2024

BUY
$23.68 - $38.51 $2.8 Million - $4.56 Million
118,296 New
118,296 $3 Billion
Q1 2023

May 15, 2023

SELL
$23.68 - $38.51 $6,701 - $10,898
-283 Reduced 0.24%
118,296 $3 Million
Q4 2022

May 10, 2024

SELL
$28.0 - $40.56 $37,660 - $54,553
-1,345 Reduced 1.12%
118,579 $4.81 Million
Q4 2022

Jun 14, 2023

BUY
$28.0 - $40.56 $7,924 - $11,478
283 Added 0.24%
118,579 $4.81 Million
Q4 2022

Mar 22, 2023

SELL
$28.0 - $40.56 $37,660 - $54,553
-1,345 Reduced 1.12%
118,579 $4.81 Million
Q4 2022

Feb 15, 2023

SELL
$28.0 - $40.56 $37,660 - $54,553
-1,345 Reduced 1.12%
118,579 $4.81 Million
Q3 2022

May 10, 2024

SELL
$29.63 - $48.31 $21,689 - $35,362
-732 Reduced 0.61%
119,924 $3.96 Million
Q3 2022

Jun 14, 2023

BUY
$29.63 - $48.31 $48,237 - $78,648
1,628 Added 1.38%
119,924 $3.96 Million
Q3 2022

Mar 22, 2023

SELL
$29.63 - $48.31 $21,689 - $35,362
-732 Reduced 0.61%
119,924 $3.96 Million
Q3 2022

Nov 14, 2022

SELL
$29.63 - $48.31 $21,689 - $35,362
-732 Reduced 0.61%
119,924 $3.96 Million
Q2 2022

May 10, 2024

BUY
$27.79 - $50.61 $12,199 - $22,217
439 Added 0.37%
120,656 $4.25 Million
Q2 2022

Jun 20, 2023

BUY
$27.79 - $50.61 $65,584 - $119,439
2,360 Added 1.99%
120,656 $4.25 Million
Q2 2022

Mar 22, 2023

BUY
$27.79 - $50.61 $12,199 - $22,217
439 Added 0.37%
120,656 $4.25 Million
Q2 2022

Aug 11, 2022

BUY
$27.79 - $50.61 $12,199 - $22,217
439 Added 0.37%
120,656 $4.25 Million
Q1 2022

May 10, 2024

BUY
$39.62 - $69.97 $4.76 Million - $8.41 Million
120,217 New
120,217 $5.53 Million
Q1 2022

Jun 20, 2023

BUY
$39.62 - $69.97 $76,110 - $134,412
1,921 Added 1.62%
120,217 $5.53 Million
Q1 2022

Mar 22, 2023

BUY
$39.62 - $69.97 $1.38 Million - $2.44 Million
34,891 Added 40.89%
120,217 $5.53 Million
Q1 2022

May 12, 2022

BUY
$39.62 - $69.97 $1.38 Million - $2.44 Million
34,891 Added 40.89%
120,217 $5.53 Million
Q4 2021

May 17, 2024

SELL
$58.09 - $82.51 $44,148 - $62,707
-760 Reduced 0.88%
85,326 $5.66 Million
Q4 2021

Jun 21, 2023

SELL
$58.09 - $82.51 $1.92 Million - $2.72 Million
-32,970 Reduced 27.87%
85,326 $5.66 Million
Q4 2021

Mar 22, 2023

SELL
$58.09 - $82.51 $44,148 - $62,707
-760 Reduced 0.88%
85,326 $5.66 Million
Q4 2021

Feb 15, 2022

SELL
$58.09 - $82.51 $44,148 - $62,707
-760 Reduced 0.88%
85,326 $5.66 Million
Q3 2021

May 17, 2024

SELL
$58.38 - $84.96 $112,206 - $163,293
-1,922 Reduced 2.18%
86,086 $5.37 Million
Q3 2021

Jun 21, 2023

SELL
$58.38 - $84.96 $1.88 Million - $2.74 Million
-32,210 Reduced 27.23%
86,086 $5.37 Million
Q3 2021

Mar 22, 2023

SELL
$58.38 - $84.96 $112,206 - $163,293
-1,922 Reduced 2.18%
86,086 $5.37 Million
Q3 2021

Nov 15, 2021

SELL
$58.38 - $84.96 $112,206 - $163,293
-1,922 Reduced 2.18%
86,086 $5.37 Million
Q2 2021

May 17, 2024

SELL
$62.15 - $90.32 $210,874 - $306,455
-3,393 Reduced 3.71%
88,008 $7.29 Million
Q2 2021

Jun 21, 2023

SELL
$62.15 - $90.32 $1.88 Million - $2.74 Million
-30,288 Reduced 25.6%
88,008 $7.29 Million
Q2 2021

Mar 22, 2023

SELL
$62.15 - $90.32 $210,874 - $306,455
-3,393 Reduced 3.71%
88,008 $7.29 Million
Q2 2021

Aug 16, 2021

SELL
$62.15 - $90.32 $210,874 - $306,455
-3,393 Reduced 3.71%
88,008 $7.29 Million
Q1 2021

May 17, 2024

SELL
$61.35 - $90.47 $2.12 Million - $3.12 Million
-34,481 Reduced 27.39%
91,401 $6.06 Million
Q1 2021

Jun 26, 2023

SELL
$61.35 - $90.47 $1.65 Million - $2.43 Million
-26,895 Reduced 22.74%
91,401 $6.06 Billion
Q1 2021

Mar 22, 2023

SELL
$61.35 - $90.47 $294,970 - $434,979
-4,808 Reduced 5.0%
91,401 $6.06 Million
Q1 2021

May 14, 2021

SELL
$61.35 - $90.47 $294,970 - $434,979
-4,808 Reduced 5.0%
91,401 $6.06 Million
Q4 2020

May 24, 2024

SELL
$43.82 - $85.37 $194,210 - $378,359
-4,432 Reduced 4.4%
96,209 $7.38 Million
Q4 2020

Jun 22, 2023

SELL
$43.82 - $85.37 $967,852 - $1.89 Million
-22,087 Reduced 18.67%
96,209 $7.38 Million
Q4 2020

Mar 22, 2023

SELL
$43.82 - $85.37 $194,210 - $378,359
-4,432 Reduced 4.4%
96,209 $7.38 Million
Q4 2020

Feb 16, 2021

SELL
$43.82 - $85.37 $194,210 - $378,359
-4,432 Reduced 4.4%
96,209 $7.38 Million
Q3 2020

May 24, 2024

SELL
$33.21 - $51.27 $132,209 - $204,105
-3,981 Reduced 3.81%
100,641 $4.33 Billion
Q3 2020

Jun 26, 2023

SELL
$33.21 - $51.27 $586,322 - $905,171
-17,655 Reduced 14.92%
100,641 $4.33 Million
Q3 2020

Mar 22, 2023

SELL
$33.21 - $51.27 $132,209 - $204,105
-3,981 Reduced 3.81%
100,641 $4.33 Million
Q3 2020

Nov 13, 2020

SELL
$33.21 - $51.27 $132,209 - $204,105
-3,981 Reduced 3.81%
100,641 $4.33 Million
Q2 2020

May 24, 2024

SELL
$26.12 - $43.27 $555,311 - $919,920
-21,260 Reduced 16.89%
104,622 $4.52 Billion
Q2 2020

Jun 26, 2023

SELL
$26.12 - $43.27 $357,164 - $591,673
-13,674 Reduced 11.56%
104,622 $4.52 Million
Q2 2020

Mar 22, 2023

BUY
$26.12 - $43.27 $122,450 - $202,849
4,688 Added 4.69%
104,622 $4.52 Million
Q2 2020

Aug 14, 2020

BUY
$26.12 - $43.27 $122,450 - $202,849
4,688 Added 4.69%
104,622 $4.52 Million
Q1 2020

Jul 12, 2023

SELL
$20.56 - $63.12 $377,522 - $1.16 Million
-18,362 Reduced 15.52%
99,934 $2.88 Million
Q1 2020

Mar 22, 2023

BUY
$20.56 - $63.12 $60,816 - $186,708
2,958 Added 3.05%
99,934 $2.88 Million
Q1 2020

May 15, 2020

BUY
$20.56 - $63.12 $60,816 - $186,708
2,958 Added 3.05%
99,934 $2.88 Million
Q4 2019

Jul 12, 2023

SELL
$28.14 - $73.01 $599,944 - $1.56 Million
-21,320 Reduced 18.02%
96,976 $6.15 Million
Q4 2019

Mar 22, 2023

BUY
$28.14 - $73.01 $1.58 Million - $4.09 Million
56,016 Added 136.76%
96,976 $6.15 Million
Q4 2019

Feb 14, 2020

BUY
$28.14 - $73.01 $1.58 Million - $4.09 Million
56,016 Added 136.76%
96,976 $6.15 Million
Q3 2019

Jul 12, 2023

SELL
$26.26 - $34.86 $2.03 Million - $2.7 Million
-77,336 Reduced 65.37%
40,960 $1.15 Million
Q2 2019

Jul 12, 2023

SELL
$17.43 - $28.82 $1.35 Million - $2.23 Million
-77,336 Reduced 65.37%
40,960 $1.09 Million
Q1 2019

Jul 13, 2023

SELL
$12.05 - $20.18 $931,898 - $1.56 Million
-77,336 Reduced 65.37%
40,960 $751,000
Q4 2018

Jul 13, 2023

SELL
$10.74 - $19.7 $830,588 - $1.52 Million
-77,336 Reduced 65.37%
40,960 $508,000
Q4 2018

Mar 22, 2023

SELL
$10.74 - $19.7 $242,638 - $445,062
-22,592 Reduced 35.55%
40,960 $508,000
Q4 2018

Feb 14, 2019

SELL
$10.74 - $19.7 $242,638 - $445,062
-22,592 Reduced 35.55%
40,960 $509,000
Q3 2018

Jul 13, 2023

SELL
$14.0 - $20.3 $1.08 Million - $1.57 Million
-77,336 Reduced 65.37%
40,960 $785,000
Q3 2018

Mar 22, 2023

SELL
$14.0 - $20.3 $770,378 - $1.12 Million
-55,027 Reduced 46.41%
63,552 $1.22 Million
Q3 2018

Nov 14, 2018

BUY
$14.0 - $20.3 $316,288 - $458,617
22,592 Added 55.16%
63,552 $1.22 Million
Q2 2018

Aug 15, 2018

BUY
$6.37 - $14.02 $260,915 - $574,259
40,960 New
40,960 $557,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.08B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.